









Markets
/
Stocks
/
nasdaq-lh
/

Labcorp Holdings Inc

252.250USD

+4.110+1.66%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

20.94BMarket Cap

24.48P/E TTM



Labcorp Holdings Inc

252.250

+4.110+1.66%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Labcorp Holdings Inc

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Labcorp Holdings Inc's Score

Industry at a Glance

Industry Ranking

14 / 78

Overall Ranking

82 / 4623

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 21 analysts

Buy

Current Rating

298.831

Target Price

+15.07%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Labcorp Holdings Inc Highlights

StrengthsRisks

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.

Undervalued

The company’s latest PE is 24.20, at a low 3-year percentile range.

Fairly Valued

The company’s latest PE is 27.16, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 83.24M shares, increasing 1.09% quarter-over-quarter.

Held by Diamond Hill Capital

Star Investor Diamond Hill Capital holds 1.82M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.29.

Financial Health

Currency: USD Updated: 2025-10-29

The company's current financial score is 8.73, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 3.56B, representing a year-over-year increase of 8.58%, while its net profit experienced a year-over-year increase of 54.22%.

Score

Industry at a Glance

Previous score

8.73

Change



Financials

6.89

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.37

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.78

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.06

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.57

Key Metrics

Free cash flow

No Data

Labcorp Holdings Inc's Company Valuation

Currency: USD Updated: 2025-10-29

The company’s current valuation score is 5.66, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 24.20, which is 100.22% below the recent high of 48.46 and 46.07% above the recent low of 13.05.

Score

Industry at a Glance

Previous score

5.66

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 14/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-29

The company’s current earnings forecast score is 8.29, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Labcorp Holdings Inc is 300.00, with a high of 342.00 and a low of 260.00.

Score

Industry at a Glance

Previous score

8.29

Change

Support & Resistance

No Data

Analyst Rating

Based on 21 analysts

Buy

Current Rating

298.831

Target Price

+20.43%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Labcorp Holdings Inc

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-29

The company’s current price momentum score is 6.54, which is lower than the Healthcare Providers & Services industry's average of 7.13. Sideways: Currently, the stock price is trading between the resistance level at 278.57 and the support level at 232.85, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.81

Change

-0.27

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-7.795

Sell

RSI(14)

29.851

Sell

STOCH(KDJ)(9,3,3)

9.608

Oversold

ATR(14)

7.352

High Vlolatility

CCI(14)

-173.461

Sell

Williams %R

90.529

Oversold

TRIX(12,20)

-0.096

Sell

StochRSI(14)

21.893

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

263.062

Sell

MA10

274.315

Sell

MA20

276.540

Sell

MA50

277.267

Sell

MA100

268.875

Sell

MA200

255.182

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 100.16%, representing a quarter-over-quarter increase of 2.18%. The largest institutional shareholder is The Vanguard, holding a total of 9.84M shares, representing 11.86% of shares outstanding, with 2.85% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.84M

+1.61%

BlackRock Institutional Trust Company, N.A.

4.40M

-4.41%

State Street Investment Management (US)

3.86M

+0.94%

Victory Capital Management Inc.

2.20M

+3588.62%

Select Equity Group, L.P.

2.13M

-3.93%

Geode Capital Management, L.L.C.

2.11M

+2.16%

Allspring Global Investments, LLC

2.00M

+2.22%

Diamond Hill Capital Management Inc.

Star Investors

1.82M

-6.56%

Wellington Management Company, LLP

1.82M

+584.94%

BlackRock Financial Management, Inc.

1.57M

-15.13%

Risk Assessment

Currency: USD Updated: 2025-10-29

The company’s current risk assessment score is 9.63, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.91. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.